Understanding Blood-Based Biomarkers in Alzheimer Disease
Neurology® Podcast
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at .
info_outline
May 2025 Recall: Topics on Myasthenia Gravis
Neurology® Podcast
The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries...
info_outline
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Neurology® Podcast
Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in . Disclosures can be found at .
info_outline
Women With Genetic Epilepsies
Neurology® Podcast
Dr. Halley Alexander talks with Dr. Paula Marques about sex differences in genetically determined epilepsies. Read the related article in . Disclosures can be found at .
info_outline
Understanding the Classification of Headaches and the Science Behind Them
Neurology® Podcast
Dr. Tesha Monteith talks with Dr. Peter Goadsby about advances in headache science and classification. Read the editorial about . Disclosures can be found at .
info_outline
BTK Inhibitors in Multiple Sclerosis Treatment
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis. Read the related article on Tolebrutinib versus Teriflunomide in . Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in . Disclosures can be found at .
info_outline
The Landscape of Adult Neurology Residency Didactic Curricula in the United States
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Harry W. Sutherland about diversity in teaching methods, the balance between clinical responsibilities and educational opportunities, and innovative models like the academic half day. Read the related article in . Disclosures can be found at .
info_outline
Characterizing Prodrome in Migraine
Neurology® Podcast
Dr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice. Read the related article with . Disclosures can be found at .
info_outline
Reducing Health Care Costs with Functional Seizures Clinic Referral
Neurology® Podcast
Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic. Read the related article with . Disclosures can be found at .
info_outline
Neurology® Open Access
Neurology® Podcast
Neurology® Open Access has officially launched. In this episode, Dr. Jeff Ratliff and NOA Editor, Dr. Amy C. Kunchok share insights about Neurology® Open Access (NOA). Read more about in this editorial, and visit the website. Disclosures can be found at .
info_outlineDr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.
Read the related article with Neurology® Clinical Practice.
Disclosures can be found at Neurology.org.